| Literature DB >> 27057087 |
Richard A Ingebrigtsen1, Espen Hansen2, Jeanette Hammer Andersen2, Hans Christian Eilertsen1.
Abstract
Isolates of five pelagic North Atlantic marine diatoms (Bacillariophyceae): Attheya longicornis, Chaetoceros socialis, Chaetoceros furcellatus, Skeletonema marinoi and Porosira glacialis were cultivated in large photobioreactors at two light and two temperature regimes to test if this affected bioactivity. We screened for bioactivity in assays representing five different therapeutic areas: diabetes II (PTP1b), cancer (melanoma cells, A2058), anti-oxidants (FRAP), immunomodulation (TNFa) and anti-infection (MRSA, Enterococcus faecalis, Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa). All the diatom strains showed activity in two or more assays. We detected differences in bioactivity both between species and within species cultivated with different light and temperature regimes. Our results demonstrate the potential for a more exhaustive exploitation of diatom metabolites that can be obtained by manipulation of the cultivation conditions.Entities:
Keywords: Bioactivity; Diatoms; OSMAC method
Year: 2015 PMID: 27057087 PMCID: PMC4789199 DOI: 10.1007/s10811-015-0631-4
Source DB: PubMed Journal: J Appl Phycol ISSN: 0921-8971 Impact factor: 3.215
Light and temperature regimes applied for the cultivations
| Species | Weighted mean temperature (°C) | Weighted mean scalar irradiance (μmol photons m−2 s−1) | ||
|---|---|---|---|---|
| High | Low | High | Low | |
|
| 4.3 | 76 | ||
| 9 | 30 | |||
| 9 | 130 | |||
|
| 4.3 | 30 | ||
| 5 | 130 | |||
| 8.5 | 68 | |||
| 9 | 130 | |||
|
| 4.5 | 130 | ||
| 6.6 | 35 | |||
|
| 3.3 | 93 | ||
| 4.5 | 160 | |||
| 6.5 | 80 | |||
| 7.1 | 135 | |||
|
| 5.6 | 115 | ||
| 8.5 | 55 | |||
| 8.7 | 93 | |||
Each strain was cultivated at a high and a low light and temperature regime. The light intensities and temperatures applied for cultivation were different between the strains due to differences in their temperature and irradiance tolerances. Light intensities given are start values. Note that “high” temperature in this context with e.g. the obligate cold-water species P. glacialis is only around 7 °C
Main components of Substral™ (Scotts Company (Nordics) A/S)) and Guillard’s f/2 marine nutrient enrichment solution (Sigma–Aldrich)
| Substral | Guillard’s f/2 | ||
|---|---|---|---|
| Component | Contents (mg mL−1) | Component | Contents (mg mL−1) |
| Nitrate | 39.24 | Sodium nitrate | 75 |
| Ammonia | 32.08 | Sodium phosphate | 4.41 |
| Phosphate | 15.44 | EDTA disodium·2H2O | 4.36 |
| Trace minerals/ | Trace amounts | Ferric chloride·6H2O | 3.15 |
| Vitamins | Trace amounts | Trace minerals/ | Trace amounts |
| Vitamins | Trace amounts | ||
Solvent gradient used for HPLC separation: 40 fractions and 1 min. fractions
| Time (min) | Solvent A (%) | Solvent B (%) | Flow rate (mL min−1) |
|---|---|---|---|
| 0 | 80 | 20 | 6 |
| 2 | 80 | 20 | 6 |
| 30 | 0 | 100 | 6 |
| 40 | 0 | 100 | 6 |
Solvent A is Milli-Q H2O, and solvent B is acetonitrile
Overview of all assay results from all tests in all assays combined (n = 5520)
| Result | Active | Weak activity | Inactive | Sum | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cultivation conditions | Low temp–low light | Low temp–high light | High temp–low light | High temp–high light | Total | Low temp–low light | Low temp–high light | High temp–low light | High temp–high light | Total | Low temp–low light | Low temp–high light | High temp–low light | High temp–high light | Total | Total | Hit rate % |
| Species: assay | |||||||||||||||||
|
| 9 | 12 | 18 | 39 | 4 | 1 | 5 | 10 | 347 | 347 | 337 | 1031 | 1080 | 3.6 % | |||
| Melanoma | 2 | 4 | 5 | 11 | – | – | – | – | – | 38 | – | 36 | 35 | 109 | 120 | 9.2 % | |
|
| – | – | – | – | – | – | – | – | – | – | 40 | – | 40 | 40 | 120 | 120 | 0.0 % |
|
| – | – | – | – | – | – | – | – | 2 | 2 | 40 | – | 40 | 38 | 118 | 120 | 0.0 % |
| FRAP | – | – | – | – | – | – | – | – | – | – | 40 | – | 40 | 40 | 120 | 120 | 0.0 % |
| MRSA | – | – | – | 1 | 1 | – | – | – | 1 | 1 | 40 | – | 40 | 38 | 118 | 120 | 0.8 % |
|
| – | – | – | – | – | – | – | – | – | – | 40 | – | 40 | 40 | 120 | 120 | 0.0 % |
| Diabetes (PTP1B) | 7 | – | 7 | 9 | 23 | 2 | – | 1 | 1 | 4 | 31 | – | 32 | 30 | 93 | 120 | 19.2 % |
|
| – | – | – | 1 | 1 | – | – | – | 1 | 1 | 40 | – | 40 | 38 | 118 | 120 | 0.8 % |
| Immunomodulating | – | – | 1 | 2 | 3 | 2 | – | – | – | 2 | 38 | – | 39 | 38 | 115 | 120 | 2.5 % |
|
| 5 | 8 | 4 | 2 | 19 | 1 | 2 | 1 | 4 | 8 | 354 | 350 | 355 | 354 | 1413 | 1440 | 1.3 % |
| Melanoma | – | 5 | – | – | 5 | – | 2 | – | – | 2 | 40 | 33 | 40 | 40 | 153 | 160 | 3.1 % |
|
| – | – | – | – | – | – | – | – | – | – | 40 | 40 | 40 | 40 | 160 | 160 | 0.0 % |
|
| – | – | – | – | – | – | – | – | – | – | 40 | 40 | 40 | 40 | 160 | 160 | 0.0 % |
| FRAP | – | – | – | – | – | – | – | – | – | – | 40 | 40 | 40 | 40 | 160 | 160 | 0.0 % |
| MRSA | – | – | – | – | – | – | – | – | – | – | 40 | 40 | 40 | 40 | 160 | 160 | 0.0 % |
|
| – | – | – | – | – | – | – | – | – | – | 40 | 40 | 40 | 40 | 160 | 160 | 0.0 % |
| Diabetes (PTP1B) | 5 | 3 | 4 | 2 | 14 | 1 | – | 1 | 4 | 6 | 34 | 37 | 35 | 34 | 140 | 160 | 8.8 % |
|
| – | – | – | – | – | – | – | – | – | – | 40 | 40 | 40 | 40 | 160 | 160 | 0.0 % |
| Immunomodulating | – | – | – | – | – | – | – | – | – | – | 40 | 40 | 40 | 40 | 160 | 160 | 0.0 % |
|
| – | 2 | 12 | – | 14 | – | 1 | 5 | – | 6 | – | 317 | 303 | – | 620 | 640 | 2.2 % |
| Melanoma | – | – | 3 | – | 3 | – | – | – | – | – | – | 40 | 37 | – | 77 | 80 | 3.8 % |
|
| – | – | – | – | – | – | – | – | – | – | – | 40 | 40 | – | 80 | 80 | 0.0 % |
|
| – | – | – | – | – | – | – | – | – | – | – | 40 | 40 | – | 80 | 80 | 0.0 % |
| FRAP | – | 2 | – | – | 2 | – | – | – | – | – | – | 38 | 40 | – | 78 | 80 | 2.5 % |
| MRSA | – | – | – | – | – | – | – | – | – | – | – | 40 | 40 | – | 80 | 80 | 0.0 % |
|
| – | – | – | – | – | – | – | – | – | – | – | 40 | 40 | – | 80 | 80 | 0.0 % |
| Diabetes (PTP1B) | – | – | 9 | – | 9 | – | 1 | 5 | – | 6 | – | 39 | 26 | – | 65 | 80 | 11.3 % |
|
| – | – | – | – | – | – | – | – | – | – | – | 40 | 40 | – | 80 | 80 | 0.0 % |
|
| 14 | 5 | 7 | – | 26 | 5 | 7 | 3 | – | 15 | 341 | 348 | 350 | 360 | 1399 | 1440 | 1.8 % |
| Melanoma | 3 | – | 3 | – | 6 | – | – | – | – | – | 37 | 40 | 37 | 40 | 154 | 160 | 3.8 % |
|
| – | – | – | – | – | – | – | – | – | – | 40 | 40 | 40 | 40 | 160 | 160 | 0.0 % |
|
| – | – | – | – | – | – | – | – | – | – | 40 | 40 | 40 | 40 | 160 | 160 | 0.0 % |
| FRAP | 2 | – | – | – | 2 | – | – | – | – | – | 38 | 40 | 40 | 40 | 158 | 160 | 1.3 % |
| MRSA | – | – | – | – | – | – | – | – | – | – | 40 | 40 | 40 | 40 | 160 | 160 | 0.0 % |
|
| – | – | – | – | – | – | – | – | – | – | 40 | 40 | 40 | 40 | 160 | 160 | 0.0 % |
| Diabetes (PTP1B) | 1 | 1 | 4 | – | 6 | 2 | – | 3 | – | 5 | 37 | 39 | 33 | 40 | 149 | 160 | 3.8 % |
|
| – | – | – | – | – | – | – | – | – | – | 40 | 40 | 40 | 40 | 160 | 160 | 0.0 % |
| Immunomodulating | 8 | 4 | – | – | 12 | 3 | 7 | – | – | 10 | 29 | 29 | 40 | 40 | 138 | 160 | 7.5 % |
|
| – | 4 | – | 1 | 5 | – | – | – | 2 | 2 | – | 316 | 280 | 317 | 913 | 920 | 0.5 % |
| Melanoma | – | 2 | – | – | 2 | – | – | – | 1 | 1 | – | 38 | 40 | 39 | 117 | 120 | 1.7 % |
|
| – | – | – | – | – | – | – | – | – | – | – | 40 | 40 | 40 | 120 | 120 | 0.0 % |
|
| – | – | – | – | – | – | – | – | – | – | – | 40 | 40 | 40 | 120 | 120 | 0.0 % |
| FRAP | – | 2 | – | 1 | 3 | – | – | – | – | – | – | 38 | – | 39 | 77 | 80 | 3.8 % |
| MRSA | – | – | – | – | – | – | – | – | – | – | – | 40 | 40 | 40 | 120 | 120 | 0.0 % |
|
| – | – | – | – | – | – | – | – | – | – | – | 40 | 40 | 40 | 120 | 120 | 0.0 % |
| Diabetes (PTP1B) | – | – | – | – | – | – | – | – | 1 | 1 | – | 40 | 40 | 39 | 119 | 120 | 0.0 % |
|
| – | – | – | – | – | – | – | – | – | – | – | 40 | 40 | 40 | 120 | 120 | 0.0 % |
| Sum | 28 | 19 | 35 | 21 | 103 | 10 | 10 | 10 | 11 | 41 | 1042 | 1331 | 1635 | 1368 | 5376 | 5520 | 1.9 % |
The results are reported as active, weakly active and inactive. There were a total of 103 hits
Percentage of active fractions in the assays (n = 5520)
| Assay | Active + weak active (%) | Active (%) |
|---|---|---|
| Melanoma | 4.7 | 4.2 |
|
| 0.0 | 0.0 |
|
| 0.3 | 0.0 |
| FRAP | 1.2 | 1.2 |
| MRSA | 0.3 | 0.2 |
|
| 0.0 | 0.0 |
| Diabetes (PTP1B) | 11.6 | 8.1 |
|
| 0.3 | 0.2 |
| Immunomodulating | 6.1 | 3.4 |
| All assays | 2.6 | 1.9 |
Fig. 1The two upper figures show examples of activity profiles from two different assays, anti-cancer assay to the left (a) and the anti-inflammatory assay to the right (b), with cutoff lines shown (active threshold). If the activity measured was above (as in the anti-inflammatory assay) or below (as in the anti-cancer assay), it is recorded as “active” or a “hit”. Presence/absence of the four geometric shapes in the species/assay intersects in the lower figure (c) depicts hit/no hit at a given cultivation condition, except “ND” indicating no data from the given cultivation condition. Thus, lack of symbol in the given species vs. assay box denotes no hit
Fisher’s exact test matrix showing P values of difference between each species and their counts of active vs. non-active HPLC fractions
| Species |
|
|
|
|
|
|---|---|---|---|---|---|
|
| – | 0.0002* | 0.1127 | 0.0052* | 0.0000* |
|
| 0.0002* | – | 0.1812 | 0.2971 | 0.0907 |
|
| 0.1127 | 0.1812 | – | 0.6044 | 0.0043* |
|
| 0.0052* | 0.2971 | 0.6044 | – | 0.0086* |
|
| 0.0000* | 0.0907 | 0.0043* | 0.0086* | – |
Significant results (P < 0.05) indicated with an asterisk (*)
Fisher’s exact test matrix showing P values of difference between the count of active vs. non-active in each cultivation condition
| Cultivation condition | Low temp–low light | Low temp–high light | High temp–low light | High temp–high light |
|---|---|---|---|---|
| Low temp–low light | – | 0.0375* | 0.4333 | 0.0586 |
| Low temp–high light | 0.0375* | – | 0.169 | 0.8742 |
| High temp–low light | 0.4333 | 0.169 | – | 0.2786 |
| High temp–high light | 0.0586 | 0.8742 | 0.2786 | – |
Significant results (P < 0.05) indicated with an asterisk (*)
Fig. 2HPLC fraction number of hits (n = 103). The x-axis is the six assays with detected hits, and the shapes indicate species. Most of the hits were detected between fractions 25 and 35